RecruitingNot ApplicableNCT07401212

GUTLINK4KIDS Intervention

The Impact of Chronic Consumption of Prebiotics on Cognitive and Affective Outcomes, Gut Microbiome Diversity and Composition in 3-5 Year Olds: a Double-blind Placebo-controlled, Parallel-groups Randomised Controlled Trial

Sponsor

University of Reading

Enrollment

106 participants

Start Date

Mar 2, 2026

Study Type

INTERVENTIONAL

Conditions

Sleep Cognition Emotion Regulation Temperament

Summary

This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.

Eligibility

Min Age: 3 YearsMax Age: 5 Years

Inclusion Criteria1

Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).

Exclusion Criteria3

Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
Children with food allergies and intolerances

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.